{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:30:16Z","timestamp":1788777016660,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-025-01086-y","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:27:44Z","timestamp":1770103664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful use of Remcyte\u00ae-based continuous hemodiafiltration in a case of refractory CRS and ICANS complicated by tumor lysis syndrome\u2013associated AKI"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0571-6617","authenticated-orcid":false,"given":"Daichi","family":"Yomogida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinjiro","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Koshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"12","key":"1086_CR1","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1200\/JCO.22.01725","volume":"41","author":"C Thieblemont","year":"2023","unstructured":"Thieblemont C, Phillips T, Ghesquieres H, Cheah CY, Clausen MR, Cunningham D, et al. Epcoritamab, a novel, subcutaneous CD3xCD20 bispecific T-cell-engaging antibody, in relapsed or refractory large B-cell lymphoma: dose expansion in a phase I\/II trial. J Clin Oncol. 2023;41(12):2238\u201347. https:\/\/doi.org\/10.1200\/JCO.22.01725.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1086_CR2","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/2159-8290.CD-17-0698","volume":"7","author":"J Gust","year":"2017","unstructured":"Gust J, Hay KA, Hanafi LA, Li D, Myerson D, Gonzalez-Cuyar LF, et al. Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells. Cancer Discov. 2017;7(12):1404\u201319. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0698.","journal-title":"Cancer Discov"},{"issue":"15","key":"1086_CR3","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.2169\/internalmedicine.2347-23","volume":"63","author":"K Nakashima","year":"2024","unstructured":"Nakashima K, Kitani K, Kono K, Yoshihara K, Kawakado K, Kobayashi M, et al. Cytokine release syndrome more than two years after pembrolizumab introduction. Intern Med. 2024;63(15):2163\u20136. https:\/\/doi.org\/10.2169\/internalmedicine.2347-23.","journal-title":"Intern Med"},{"issue":"1","key":"1086_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000534295","volume":"53","author":"T Yamamoto","year":"2024","unstructured":"Yamamoto T, Kunomura S, Taniguchi T. Cytokine adsorption effects of a novel hemofiltration column for the treatment of experimental endotoxemia. Blood Purif. 2024;53(1):61\u20139. https:\/\/doi.org\/10.1159\/000534295.","journal-title":"Blood Purif"},{"issue":"1","key":"1086_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40364-018-0116-0","volume":"6","author":"Z Wang","year":"2018","unstructured":"Wang Z, Han W. Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy. Biomark Res. 2018;6(1):4. https:\/\/doi.org\/10.1186\/s40364-018-0116-0.","journal-title":"Biomark Res"},{"issue":"10","key":"1086_CR6","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.bbmt.2019.06.003","volume":"25","author":"M Nishimoto","year":"2019","unstructured":"Nishimoto M, Hirose A, Koh H, Nakamae M, Nanno S, Okamura H, et al. Clinical impacts of using serum IL-6 level as an indicator of cytokine release syndrome after HLA-haploidentical transplantation with post-transplantation cyclophosphamide. Biol Blood Marrow Transplant. 2019;25(10):2061\u20139. https:\/\/doi.org\/10.1016\/j.bbmt.2019.06.003.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"1086_CR7","first-page":"759","volume":"18","author":"BD Santomasso","year":"2021","unstructured":"Santomasso BD, Taraseviciute A, Park JH. CAR T cell\u2013associated neurotoxicity: clinical presentation, pathophysiology, and treatment. Nat Rev Clin Oncol. 2021;18(12):759\u201376.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"1086_CR8","first-page":"625","volume":"23","author":"J Gust","year":"2017","unstructured":"Gust J, Hay KA, Hanafi L-A, Li D, Myerson D, Gonzalez-Cuyar LF, et al. Endothelial activation and blood\u2013brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells. Nat Med. 2017;23(6):625\u201334.","journal-title":"Nat Med"},{"key":"1086_CR9","doi-asserted-by":"publisher","first-page":"577027","DOI":"10.3389\/fimmu.2020.577027","volume":"11","author":"J Gust","year":"2020","unstructured":"Gust J, Ponce R, Liles WC, Garden GA, Turtle CJ. Cytokines in CAR T cell\u2013associated neurotoxicity. Front Immunol. 2020;11:577027.","journal-title":"Front Immunol"},{"issue":"4","key":"1086_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","volume":"25","author":"DW Lee","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL, Ghobadi A, Turtle CJ, Brudno JN, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant. 2019;25(4):625\u201338. https:\/\/doi.org\/10.1016\/j.bbmt.2018.12.758.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"21","key":"1086_CR11","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.2169\/internalmedicine.5922-20","volume":"60","author":"M Yomota","year":"2021","unstructured":"Yomota M, Mirokuji K, Sakaguchi M, Kitahara Y, Chin F, Setoguchi K, et al. Cytokine release syndrome induced by immune-checkpoint inhibitor therapy for non-small-cell lung cancer. Intern Med. 2021;60(21):3459\u201362. https:\/\/doi.org\/10.2169\/internalmedicine.5922-20.","journal-title":"Intern Med"},{"key":"1086_CR12","unstructured":"Yakoub-Agha I, D\u2019Aveni M, Castagna L, Chabannon C (2022) EBMT\/EHA CAR-T Cell Handbook. In: European Society for Blood and Marrow Transplantation. 2nd ed. Available from: https:\/\/www.ebmt.org"},{"issue":"10","key":"1086_CR13","first-page":"e003436","volume":"9","author":"M-A Perales","year":"2021","unstructured":"Perales M-A, Annesley CE, Barrett DM, Ceppi F, Finney OC, Gardner RA, et al. Management of toxicities associated with CAR T cell therapy: 2021 ASTCT and SITC clinical practice guideline. J Immunother Cancer. 2021;9(10):e003436.","journal-title":"J Immunother Cancer"},{"key":"1086_CR14","unstructured":"Treatment With Anakinra After Initially Receiving Tocilizumab for Cytokine Release Syndrome"},{"key":"1086_CR15","unstructured":"JHOP - December 2024 Vol 14, No 6 - Original Research, CAR T-Cell Therapy, Adverse Events, Immunotherapy, Monoclonal Antibodies"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01086-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-025-01086-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-025-01086-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:27:45Z","timestamp":1770103665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-025-01086-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1007\/s13730-025-01086-y","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}